Keeps Prescription Process: How the Intake Works, What Gets Prescribed, and Whether It's Worth It

What Keeps Actually Prescribes

Keeps offers two FDA-approved medications for androgenetic alopecia in men: oral finasteride 1 mg daily and topical minoxidil 5% applied twice daily. Both drugs carry decades of trial data supporting their use in male-pattern hair loss.

Finasteride works by inhibiting type II 5-alpha reductase, reducing scalp dihydrotestosterone (DHT) by approximately 70% [1]. The key trial by Kaufman et al. (N=1,553) demonstrated that 1 mg finasteride daily increased hair count by a mean of 107 hairs per 1-inch target area at 2 years versus continued loss in the placebo group [1]. Topical minoxidil 5%, a vasodilator that prolongs anagen phase, was shown in the Olsen et al. trial to produce superior regrowth compared to the 2% formulation, with 45% of men rating themselves as having moderate to dense regrowth at 48 weeks [2].

Keeps does not currently offer dutasteride, topical finasteride, oral minoxidil, or combination compounded formulations. This matters clinically. A 2019 meta-analysis in the Journal of the American Academy of Dermatology found that dutasteride 0.5 mg produced statistically greater hair count increases than finasteride 1 mg at 24 weeks [3]. Patients who want these alternatives will need a different provider.

How the Intake Process Works Step by Step

The Keeps consultation is asynchronous, meaning you never sit in a live video call. You complete a medical questionnaire, upload photographs of your hairline and crown from specific angles, and a licensed physician or nurse practitioner reviews everything within 24 to 48 hours.

The questionnaire asks about current medications, medical history (liver disease, prostate conditions, depression history), prior hair loss treatments, and goals. The photo requirement includes front-facing, top-down, and temporal views. These images serve as the baseline for tracking treatment response at follow-up reviews every 90 days.

If the clinician determines you are a candidate, a prescription is written to the Keeps pharmacy and shipped directly. If you are not a candidate (contraindications, insufficient hair loss, or suspicion of a non-androgenetic etiology like alopecia areata), the clinician sends a message explaining why and may recommend an in-person dermatology referral.

One limitation: the asynchronous model means nuanced conversations about sexual side effects, dosing adjustments, or combination protocols can take multiple message exchanges over days rather than the 15 minutes a synchronous telehealth visit would allow.

Is the Keeps Intake Clinically Adequate?

The American Academy of Dermatology (AAD) guidelines for androgenetic alopecia state that diagnosis is primarily clinical, based on pattern distribution and progressive miniaturization [4]. A photograph-based review by a licensed clinician meets this threshold for most straightforward cases of Norwood II through V pattern loss.

Where the model falls short is in differential diagnosis. Telogen effluvium, alopecia areata, frontal fibrosing alopecia, and thyroid-related hair loss can all mimic early androgenetic alopecia in photographs. The AAD guidelines recommend dermoscopy or scalp biopsy when the pattern is atypical [4]. Keeps does not offer dermoscopy review, and their intake photos are standard smartphone images without magnification.

For a 28-year-old man with obvious temple recession and vertex thinning progressing over 3 years, the Keeps intake is likely sufficient. For a 45-year-old with diffuse thinning, no family history, and recent weight loss, an in-person evaluation with labs (TSH, ferritin, DHEA-S) would be more appropriate.

Keeps Cost Breakdown vs. Alternatives

Keeps prices generic finasteride at roughly $75 to $85 per quarter and topical minoxidil at $40 to $60 per quarter. These prices sit above what you would pay at a retail pharmacy with a GoodRx coupon (generic finasteride 1 mg can cost as little as $9 to $15 for 90 tablets at Costco or Walmart) but below what branded telehealth competitors charge for similar formulations.

Hims, the most direct competitor, prices its finasteride subscription comparably at around $70 to $90 per quarter but offers additional options including topical finasteride-minoxidil spray and oral minoxidil [5]. Roman (Ro) offers finasteride starting at approximately $68 per quarter. Both Hims and Roman also provide synchronous video consultations as an option.

The "free consultation" framing deserves scrutiny. The consultation cost is bundled into the medication subscription price. If the clinician declines to prescribe, you pay nothing, but you also have no medication. This is standard across D2C telehealth hair loss companies and not unique to Keeps.

Finasteride Safety: What the Keeps Intake Should Tell You

The Keeps intake questionnaire screens for finasteride contraindications, but the depth of counseling about sexual adverse effects varies by clinician. The original Merck trials reported sexual side effects (decreased libido, erectile dysfunction, ejaculation disorder) in 3.8% of finasteride users versus 2.1% on placebo [1]. These differences were statistically significant but modest in absolute terms.

The post-finasteride syndrome (PFS) hypothesis, describing persistent sexual, neurological, and psychological symptoms after drug discontinuation, remains controversial. A 2023 systematic review in the Journal of Clinical Medicine found that while persistent symptoms are reported in case series, no prospective controlled trial has established a causal mechanism or confirmed prevalence above background rates [6]. The National Institutes of Health funded a prospective study (Clinical Trial NCT04324021) that is ongoing.

What responsible prescribing requires: informed consent that sexual side effects occur at low rates during use, that they are reversible upon discontinuation in the vast majority, and that rare reports of persistent effects exist without established prevalence data. Whether the Keeps asynchronous message format delivers this nuance consistently depends entirely on the individual clinician reviewing your case.

Efficacy Timeline: When to Expect Results

Hair growth is slow biology. The anagen phase lasts 2 to 6 years, and follicular miniaturization reversal does not produce visible results quickly.

Clinical trial data sets clear expectations. In the Kaufman et al. study, statistically significant hair count differences between finasteride and placebo emerged at 6 months, with continued improvement through 24 months [1]. For minoxidil, the Olsen et al. data showed peak regrowth at approximately 48 weeks [2]. The AAD guidelines recommend a minimum 12-month trial before assessing treatment failure [4].

Keeps sends follow-up photo requests at 90-day intervals. This is appropriate for tracking adherence and grossly visible changes, but meaningful photographic differences typically require 6 to 12 months of comparison. Patients who expect visible regrowth at 3 months will likely be disappointed regardless of provider.

Is Keeps Legit? Regulatory and Pharmacy Verification

Keeps operates through licensed clinicians in each state where they prescribe and dispenses through licensed pharmacies. They are not an "online pharmacy" in the gray-market sense. The medications dispensed are FDA-approved generics manufactured by established pharmaceutical companies.

The company was founded in 2018 and has processed over 1 million consultations according to their public reporting. They are accredited by LegitScript, which verifies compliance with pharmacy licensing, clinician credentialing, and controlled substance regulations [7].

The distinction between "legit" and "optimal" matters here. Keeps is a legitimate telehealth service prescribing real medications through licensed providers. Whether the asynchronous intake provides the same quality of care as a dermatologist visit is a separate question. For straightforward androgenetic alopecia, the clinical outcome (receiving finasteride and/or minoxidil with periodic monitoring) is identical regardless of whether the prescription came from Keeps or a local dermatologist.

Who Should Skip Keeps and See a Dermatologist Instead

Certain presentations require more than a photograph review. The following scenarios warrant an in-person board-certified dermatologist rather than any asynchronous telehealth platform:

Diffuse thinning without clear pattern distribution. Rapid onset (noticeable loss over weeks rather than months or years). Scalp symptoms such as itching, burning, scaling, or scarring. Age under 18. Female-pattern hair loss (Keeps only treats men). Hair loss associated with systemic symptoms like fatigue, weight change, or joint pain. Prior treatment failure on finasteride and minoxidil, where PRP, dutasteride, or surgical options require detailed discussion.

The Endocrine Society guidelines also recommend evaluating testosterone levels in men with hair loss accompanied by gynecomastia, sexual dysfunction, or loss of muscle mass, as these may indicate hypogonadism requiring treatment beyond hair-specific therapy [8].

How Keeps Compares on Treatment Breadth

The D2C telehealth hair loss market has expanded significantly since 2020. A fair comparison requires examining what each platform can actually prescribe.

Keeps offers finasteride 1 mg oral and minoxidil 5% topical. That's it. Hims offers those same options plus topical finasteride 0.1% with minoxidil 6%, oral minoxidil 2.5 mg, and a topical spray combining finasteride, minoxidil, and biotin [5]. Happy Head and Strut Health offer compounded topical formulations with varying concentrations. Some platforms now offer dutasteride off-label for hair loss based on the Gubelin Harcha et al. phase III data showing superiority over finasteride [3].

For many men, finasteride 1 mg plus topical minoxidil 5% is the appropriate first-line regimen, and Keeps delivers exactly that. But if you want access to low-dose oral minoxidil (which a 2022 systematic review in the Journal of the American Academy of Dermatology found effective for androgenetic alopecia at doses of 1.25 to 5 mg daily [9]), or topical finasteride (which may reduce systemic DHT suppression and associated sexual side effects per a 2022 randomized trial [10]), Keeps cannot provide those options.

The Subscription Model: Convenience vs. Lock-In

Keeps auto-ships every quarter. You can pause or cancel anytime, but the business model relies on retention. Hair loss treatment is inherently long-term (stopping finasteride leads to resumed hair loss within 6 to 12 months [1]), so a subscription makes pharmacological sense even if it also serves the company's revenue model.

The quarterly cadence means 90-day medication supplies. If you experience side effects and want to discontinue at week 3, you have already paid for the full quarter. Keeps does not offer per-month billing on most plans. Compare this to a retail pharmacy prescription where your dermatologist writes a 30-day supply with refills, allowing you to stop at any monthly interval without pre-payment.

Follow-up messages with the prescribing clinician are included at no extra cost, which is genuinely useful for dose adjustment discussions or side effect management. You are not charged per interaction, removing a financial barrier to asking questions.

Bottom Line for Prospective Patients

Keeps solves a real access problem. Many men with obvious male-pattern hair loss delay treatment because scheduling a dermatologist appointment takes weeks, costs a specialist copay, and feels disproportionate to requesting a well-studied generic medication. The Keeps intake delivers that medication within 48 hours for roughly the same monthly cost as a coffee subscription.

The tradeoff is clinical depth. You get a licensed clinician reviewing your photos, but you do not get dermoscopy, labs, or the option to pivot to dutasteride or oral minoxidil if first-line therapy fails. For men with clear-cut Norwood II to V pattern loss, no red-flag symptoms, and no contraindications, Keeps is a reasonable starting point. For anything more complex, see a dermatologist who can examine your scalp directly and offer the full therapeutic arsenal.

Finasteride 1 mg daily remains the single most effective monotherapy for androgenetic alopecia based on the Kaufman et al. data (83% of men maintained or increased hair count at 2 years [1]), and the Keeps intake can get it into your hands within 2 days of completing the questionnaire.